Home NDC 46708-263-91 Ropinirole
Product NDC 46708-263
Requested package NDC 46708-263-91
11-digit product format 467080263
Labeler code 46708
Product ID 46708-263_a1e5da4e-74fc-4482-8e15-599c665f2c2f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ropinirole
Dosage form TABLET, FILM COATED, EXTENDED RELEASE
Route ORAL
Labeler Alembic Pharmaceuticals Limited
Application ANDA202786
Marketing category ANDA
Marketing start 2013-03-14
Substance ROPINIROLE HYDROCHLORIDE
Active strength 4 mg/1
Pharmacologic classes Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202786-001 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 A202786-002 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 A202786-003 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 A202786-004 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 A202786-005 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 225 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202786-001 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202786-002 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202786-003 ROPINIROLE HYDROCHLORIDE EQ 6MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202786-004 ROPINIROLE HYDROCHLORIDE EQ 8MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202786-005 ROPINIROLE HYDROCHLORIDE EQ 12MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2013-04-22 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 5 of 6 · 225 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Ropinirole
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ROPINIROLE HYDROCHLORIDE 4 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination D7ZD41RZI9 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 5 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 799054 Internal RxNorm lookup 799055 Internal RxNorm lookup 799056 Internal RxNorm lookup 824959 Internal RxNorm lookup 848582 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 46708-263-10 Ropinirole 100 in 1 CARTON TABLET, FILM COATED, EXTENDED RE 100 4 46708-263-30 Ropinirole 30 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 30 4 46708-263-31 Ropinirole 100 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 100 4 46708-263-71 Ropinirole 500 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 500 4 46708-263-90 Ropinirole 90 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 90 4 46708-263-91 Ropinirole 1000 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 1000 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 46708-263 ROPINIROLE TABLET, FILM COATED, EXTENDED RELEASE [ALEMBIC PHARMACEUTICALS LIMITED] 4 Current NDC, Legacy NDC, 6 package rows 20230129_2e01dbdd-f439-45d7-9085-2d92a1a1fee2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 46708-263-91 46708026391 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-263-91) 2013-03-14 0000-00-00 No No Current